Strategies aim to ensure cancer care for Americans ‘without financial ruin’
The cost of cancer care in the U.S. continues to rise as debate persists about how to best bring down drug prices while ensuring sufficient health care coverage. Over the last 2 decades, the advent of targeted therapies, checkpoint inhibitors and chimeric antigen receptor T-cell therapy, among others, has represented great progress in treatment of …